Skip to main content
NVDA-0.46%AAPL+1.06%GOOGL-2.28%MSFT-0.03%AMZN+0.08%TSM-0.83%SPCX-3.86%AVGO-1.13%META+1.23%TSLA-0.76%SKHY+7.05%MU-1.69%BRK-B+0.18%LLY+0.02%JPM+0.34%AMD+3.04%WMT-0.21%V-0.34%XOM+2.24%ASMLa-1.65%JNJ-0.76%INTC+1.69%MA-0.59%0700.HK-1.94%ORCL-0.50%1398.HK+0.79%BAC+0.45%ABBV+0.88%CSCO+0.24%CVX+1.91%COST-0.83%LRCX-1.43%KO-0.92%CAT-0.84%AMAT-0.83%AP2d-0.92%0005.HK-0.78%HSBA.L-1.33%UNH-1.94%DELL+0.29%MS-0.42%PG-2.02%GE-2.83%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.96%HD-1.04%GS-0.75%0939.HK+1.66%NZDJPY-2.13%CHFJPY-1.56%AUDJPY-1.45%USDJPY-1.36%EURJPY-1.27%GBPJPY-1.23%CADJPY-1.23%NZDCAD-0.92%GBPNZD+0.90%EURNZD+0.89%NZDUSD-0.80%AUDNZD+0.71%USDNOK+0.64%NZDCHF-0.60%EURNOK+0.55%CHFNOK+0.48%GBPTRY+0.41%USDZAR+0.38%AUDNOK+0.35%USDSEK+0.34%GBPHKD+0.32%CADCHF+0.32%GBPCHF+0.31%EURZAR+0.30%GBPMXN-0.28%EURCHF+0.28%GBPZAR+0.27%NOKJPY-0.26%SGDJPY+0.25%USDTHB+0.25%EURSEK+0.25%AUDCAD-0.25%USDCHF+0.22%AUDDKK-0.21%USDPLN+0.20%GBPAUD+0.20%PLNJPY+0.18%CHFSEK+0.18%EURAUD+0.18%AUDSGD-0.17%USDILS+0.16%USDMXN+0.14%USDSGD+0.13%GBPUSD+0.12%AUDCHF+0.11%USDCAD-0.11%USDTRY+0.11%EURPLN+0.11%EURHKD-0.10%AUDUSD-0.10%USDDKK+0.09%EURUSD+0.08%EURCZK-0.07%EURCNH-0.07%NZDSGD+0.06%NZDMXN+0.05%EURCAD-0.05%EURSGD+0.04%USDCOP-0.04%CHFSGD-0.03%GBPCAD-0.02%EURGBP-0.02%GBPSGD+0.01%USDHKD+0.01%EURDKK0.00%USDCNH0.00%HG1-4.08%XPTUSD-3.09%COFFEE-2.72%GAGUSD-2.35%XAGUSD-2.35%SUGAR+1.64%COCOA-1.64%COTTON+1.05%C1+0.59%S1+0.56%USOIL+0.46%GAUUSD-0.42%BTCUSD-0.37%ETHUSD0.00%USDTUSD-0.04%XRPUSD-1.15%SOLUSD-0.19%TRXUSDT+0.42%ZECUSDT-1.51%DOGEUSD-0.97%XMRUSDT-0.97%LINKUSD+0.35%XLMUSD-0.75%BCHUSDT-2.60%LTCUSD-1.65%UNIUSD-1.98%TONUSD+24.88%HBARUSDT-0.97%SUIUSD-0.91%TAOUSDT-0.44%AAVEUSD-1.88%DOTUSDT-1.92%ICPUSDT-0.76%ONDOUSDT-1.51%WLDUSDT-0.99%ATOMUSDT-2.60%ARBUSDT-0.78%JUPUSDT-2.10%INJUSDT-1.21%STXUSDT-3.07%FETUSDT-2.09%TIAUSDT-0.08%SEIUSDT-1.80%PYTHUSDT-0.74%IMXUSDT-2.27%WIFUSDT-2.44%GRTUSDT-2.30%OPUSDT-0.99%IOTAUSDT-2.05%POLUSDT-5.09%AXSUSDT-1.60%FARTCOINUSDT-2.01%EOSUSDT+0.18%DYDXUSDT+0.54%ORDIUSDT+0.40%GALAUSDT-1.97%NOTUSDT-0.68%RONINUSDT-0.71%NVDA-0.46%AAPL+1.06%GOOGL-2.28%MSFT-0.03%AMZN+0.08%TSM-0.83%SPCX-3.86%AVGO-1.13%META+1.23%TSLA-0.76%SKHY+7.05%MU-1.69%BRK-B+0.18%LLY+0.02%JPM+0.34%AMD+3.04%WMT-0.21%V-0.34%XOM+2.24%ASMLa-1.65%JNJ-0.76%INTC+1.69%MA-0.59%0700.HK-1.94%ORCL-0.50%1398.HK+0.79%BAC+0.45%ABBV+0.88%CSCO+0.24%CVX+1.91%COST-0.83%LRCX-1.43%KO-0.92%CAT-0.84%AMAT-0.83%AP2d-0.92%0005.HK-0.78%HSBA.L-1.33%UNH-1.94%DELL+0.29%MS-0.42%PG-2.02%GE-2.83%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.96%HD-1.04%GS-0.75%0939.HK+1.66%NZDJPY-2.13%CHFJPY-1.56%AUDJPY-1.45%USDJPY-1.36%EURJPY-1.27%GBPJPY-1.23%CADJPY-1.23%NZDCAD-0.92%GBPNZD+0.90%EURNZD+0.89%NZDUSD-0.80%AUDNZD+0.71%USDNOK+0.64%NZDCHF-0.60%EURNOK+0.55%CHFNOK+0.48%GBPTRY+0.41%USDZAR+0.38%AUDNOK+0.35%USDSEK+0.34%GBPHKD+0.32%CADCHF+0.32%GBPCHF+0.31%EURZAR+0.30%GBPMXN-0.28%EURCHF+0.28%GBPZAR+0.27%NOKJPY-0.26%SGDJPY+0.25%USDTHB+0.25%EURSEK+0.25%AUDCAD-0.25%USDCHF+0.22%AUDDKK-0.21%USDPLN+0.20%GBPAUD+0.20%PLNJPY+0.18%CHFSEK+0.18%EURAUD+0.18%AUDSGD-0.17%USDILS+0.16%USDMXN+0.14%USDSGD+0.13%GBPUSD+0.12%AUDCHF+0.11%USDCAD-0.11%USDTRY+0.11%EURPLN+0.11%EURHKD-0.10%AUDUSD-0.10%USDDKK+0.09%EURUSD+0.08%EURCZK-0.07%EURCNH-0.07%NZDSGD+0.06%NZDMXN+0.05%EURCAD-0.05%EURSGD+0.04%USDCOP-0.04%CHFSGD-0.03%GBPCAD-0.02%EURGBP-0.02%GBPSGD+0.01%USDHKD+0.01%EURDKK0.00%USDCNH0.00%HG1-4.08%XPTUSD-3.09%COFFEE-2.72%GAGUSD-2.35%XAGUSD-2.35%SUGAR+1.64%COCOA-1.64%COTTON+1.05%C1+0.59%S1+0.56%USOIL+0.46%GAUUSD-0.42%BTCUSD-0.37%ETHUSD0.00%USDTUSD-0.04%XRPUSD-1.15%SOLUSD-0.19%TRXUSDT+0.42%ZECUSDT-1.51%DOGEUSD-0.97%XMRUSDT-0.97%LINKUSD+0.35%XLMUSD-0.75%BCHUSDT-2.60%LTCUSD-1.65%UNIUSD-1.98%TONUSD+24.88%HBARUSDT-0.97%SUIUSD-0.91%TAOUSDT-0.44%AAVEUSD-1.88%DOTUSDT-1.92%ICPUSDT-0.76%ONDOUSDT-1.51%WLDUSDT-0.99%ATOMUSDT-2.60%ARBUSDT-0.78%JUPUSDT-2.10%INJUSDT-1.21%STXUSDT-3.07%FETUSDT-2.09%TIAUSDT-0.08%SEIUSDT-1.80%PYTHUSDT-0.74%IMXUSDT-2.27%WIFUSDT-2.44%GRTUSDT-2.30%OPUSDT-0.99%IOTAUSDT-2.05%POLUSDT-5.09%AXSUSDT-1.60%FARTCOINUSDT-2.01%EOSUSDT+0.18%DYDXUSDT+0.54%ORDIUSDT+0.40%GALAUSDT-1.97%NOTUSDT-0.68%RONINUSDT-0.71%
PB

Pulse Biosciences, Inc. (PLSE)

NASDAQ • Healthcare

$52.97
+$4.18 (+8.6%)
Market closed

Last close at September 9, 2026 at 20:00 UTC

Open$49.76
Day Range$48.43 - $58.9
Avg. Volume (3M)563.9K
Market Cap$3.6B
52 Week Range
$12.56$58.9
Next EarningsIn 55 daysNov 4, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$434K100%
Gross Profitminus cost of goods$161K37%

Fundamentals & Financials

Revenue (TTM)
$1.1M
Net Income (TTM)
-$80M
EPS (TTM)
-$1.17
ROA (TTM)
-69.27%
Current Ratio
9.63

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+1.9%Q1 2026-$0.26
+15.6%Q2 2026-$0.27
-16.1%Q3 2026-$0.36
Next

Nov 4

in 55 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Miss -16.1%

Pulse Biosciences trailed consensus on both EPS and revenue in the second fiscal quarter of 2026, reported August 6, 2026, with EPS of -$0.36 trailing the -$0.31 estimate by -$0.05 and revenue of $434,000.00 trailing the $500,000.00 estimate (-13.2%). Net income came in at roughly -$24.7 million, down 29% from about -$19.2 million a year ago, and EPS was down 29% from -$0.28 a year ago. The quarter also posted an operating loss of about -$25.3 million, alongside revenue of about $0.4 million. For the next period, consensus calls for EPS of -$0.35 on revenue of $625,000.00.

View full earnings history

About Pulse Biosciences, Inc.

Pulse Biosciences, Inc. develops medical technology and trades on the NASDAQ under PLSE. In healthcare, it operates as a maker of medical instruments and supplies built around the CellFX System, and it fits the profile of a small-cap device company founded in 2014.

Name
Pulse Biosciences, Inc.
CEO
Paul Arthur LaViolette
Website
www.pulsebiosciences.com
Industry
Healthcare
Year Founded
2014
Employees
116

Today's Snapshot

AI-generated

The day ended with PLSE 8.6% higher at 52.97, while its sector was flat. Shares changed hands at roughly twice its usual level.

Trading Volume

Above 10d avg 711.8K

1.5M

vs S&P 500 Today

Strong Outperformance

+8.99%

Updated: September 9, 2026 at 20:21 UTC

Technical Indicators

5 Buy3 Neutral0 Sell
PLSE, at about 53, shows clear technical strength: a very high ADX indicates a dominant trend while momentum gauges—RSI in the mid-60s and a bullish CCI—point to sustained upside momentum. Price is trading well above its short-, medium- and long-term moving averages, including a 200-day average well below current levels, which signals broad-based strength, and on-balance volume is supportive. Volatility is moderate and the classic pivot sits beneath the market. Technical takeaway: strong trend, momentum and volume alignment justify the strong-buy stance.
All signals
  • EMA (5 indicators)$27.36 - $50.94
    Buy
  • RSI (14)64.58
    Neutral
  • Stochastic %K (14, 3, 3)53.20
    Neutral
  • MACD Level (12, 26)3.83
    Neutral

Peers & Related Assets

DNTHDianthus Therapeutics, Inc.
$107.04-1.9%
NVCRNovocure Ltd
$15.63-7.2%
KMTSKestra Medical Technologies, Ltd.
$24.07-6.1%
STAASTAAR Surgical Company
$23.62-2.2%
OPKOPKO Health, Inc.
$1.54-3.1%
BBNXBeta Bionics, Inc.
$17.42-9.9%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.